Ratings for Ionis Pharmaceuticals (NASDAQ:IONS) were provided by 8 analysts in the past three months, showcasing a mix of bullish and bearish perspectives.
The table below summarizes their recent ratings, showcasing the evolving sentiments within the past 30 days and comparing them to the preceding months.
Bullish
Somewhat Bullish
Indifferent
Somewhat Bearish
Bearish
Total Ratings
3
5
0
0
0
Last 30D
1
1
0
0
0
1M Ago
1
1
0
0
0
2M Ago
0
0
0
0
0
3M Ago
1
3
0
0
0
Insights from analysts' 12-month price targets are revealed, presenting an average target of $67.12, a high estimate of $82.00, and a low estimate of $60.00. This current average has decreased by 3.29% from the previous average price target of $69.40.
Deciphering Analyst Ratings: An In-Depth Analysis
The analysis of recent analyst actions sheds light on the perception of Ionis Pharmaceuticals by financial experts. The following summary presents key analysts, their recent evaluations, and adjustments to ratings and price targets.
Analyst
Analyst Firm
Action Taken
Rating
Current Price Target
Prior Price Target
Yanan Zhu
Wells Fargo
Lowers
Overweight
$82.00
$85.00
Joseph Stringer
Needham
Maintains
Buy
$60.00
-
Jay Olson
Oppenheimer
Raises
Outperform
$75.00
$72.00
Joseph Stringer
Needham
Maintains
Buy
$60.00
-
Jay Olson
Oppenheimer
Raises
Outperform
$72.00
$65.00
Jay Olson
Oppenheimer
Raises
Outperform
$65.00
$63.00
Do Kim
Piper Sandler
Raises
Overweight
$63.00
$62.00
Joseph Stringer
Needham
Maintains
Buy
$60.00
-
Key Insights:
Action Taken: Analysts frequently update their recommendations based on evolving market conditions and company performance. Whether they 'Maintain', 'Raise' or 'Lower' their stance, it reflects their reaction to recent developments related to Ionis Pharmaceuticals. This information provides a snapshot of ...Full story available on Benzinga.com
Related tickers: IONS.
Read Full Article